Gebregzi, Hanna H.
Zeiger, Joanna S.
Smith, Jeffrey P.
Stuyt, Libby
Cullen, Luann
Carsella, Jim
Rogers, Daniel C.
Lafebre, Jordan
Knalfec, Jennah
Vargas, Alfredo
Diawara, Moussa M. https://orcid.org/0009-0008-4099-785X
Funding for this research was provided by:
Institute of Cannabis Research (Institute of Cannabis Research)
Article History
Received: 7 May 2024
Accepted: 14 January 2025
First Online: 23 January 2025
Declarations
:
: This study was carried out in accordance with the latest Version of the Declaration of Helsinki. This study was reviewed and approved by Colorado State University Pueblo Institutional Review Board (registration number: MD012420BM) and retrospectively registered on ClinicalTrials.gov (Identifier: NCT06074172). Participants were recruited at random and asked to participate in the study. It was made clear that participation in the study was voluntary and that participants could stop participating at any time. None of the data collected included any identifying information and could in no way be traced to individuals. There was quality assurance oversight for the study.
: The Principal Investigator verbally provided participants with information about the study and its purpose. Participants were asked to carefully read the informed consent form. The PI answered all their questions and provided clarification as needed. If the participants consented to be part of the research, they signed the informed consent form and were provided with a copy of the document before start.
: The authors (HHG, JSZ, JPS, LS, LC, JC, DCR, JL, JK, AV, MMD) declare that they have no competing interests.